Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1978 | |
| Sales | 2,399,300 |
| Cost of Goods | 1,148,000 |
| Gross Profit | 1,251,300 |
| Operating Expenses | 878,900 |
| Operating Income | 372,400 |
| Interest Expense | 71,600 |
| Other Income | 18,500 |
| Pre-tax Income | 319,300 |
| Income Tax | 105,200 |
| Net Income Continuous | 209,900 |
| Net Income | $209,900 |
| EBITDA(a) | $372,400 |